Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Dalton Transactions

• Publication date

  2018-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c7dt03637jPMID 29235601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects.

  2017cited by this paper
• The Potent Inhibitory Effect of a Naproxen‐Appended Cobalt(III)‐Cyclam Complex on Cancer Stem Cells

  2016cited by this paper
• Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration.

  2016cited by this paper
• Targeted Drug Delivery System for Platinum-based Anticancer Drugs.

  2016cited by this paper
• Fine tuning through valence bond tautomerization of ancillary ligands in ruthenium(ii) arene complexes for better anticancer activity and enzyme inhibition properties.

  2016cited by this paper
• Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level

  2016cited by this paper
• Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds.

  2016cited by this paper
• Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

  2016cited by this paper
• Inhibition of 5-lipoxygenase suppresses vascular endothelial growth factor-induced angiogenesis in endothelial cells.

  2016cited by this paper
• Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone*

  2016cited by this paper
• Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

  2016cited by this paper
• Metal-based drugs that break the rules.

  2016cited by this paper
• Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes.

  2016cited by this paper
• Platinum(iv) anticancer prodrugs - hypotheses and facts.

  2016cited by this paper
• Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs

  2016cited by this paper
• Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA

  2016cited by this paper
• Systematical investigation of binding interaction between novel ruthenium(II) arene complex with curcumin analogs and ctDNA.

  2016cited by this paper
• Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential.

  2015cited by this paper
• Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB.

  2015cited by this paper
• Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.

  2015cited by this paper
• Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance

  2015cited by this paper
• The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

  2015cited by this paper
• Linking the future of anticancer metal-complexes to the therapy of tumour metastases.

  2015cited by this paper
• Ruthenium(II) Complexes Containing Anti-Inflammatory Drugs as Ligands: Synthesis, Characterization and in vitro Cytotoxicity Activities on Cancer Cell Lines

  2015cited by this paper
• Synthesis, crystal structure and spectroscopy of bioactive Cd(II) polymeric complex of the non-steroidal anti-inflammatory drug diclofenac sodium: antiproliferative and biological activity.

  2015cited by this paper
• Anticancer Ruthenium(η 6 - p -cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives

  2014cited by this paper
• Manganese-mefenamic acid complexes exhibit high lipoxygenase inhibitory activity.

  2014cited by this paper
• Synthesis and Structure − Activity Relationship Studies of 4 ‐ ( ( 2-Hydroxy-3-methoxybenzyl ) amino ) benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase

  2014cited by this paper
• New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.

  2014cited by this paper
• NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

  2014cited by this paper
• 100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs

  2014cited by this paper
• A silver complex with ibuprofen: Synthesis, solid state characterization, DFT calculations and antibacterial assays

  2013cited by this paper
• Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives.

  2013cited by this paper
• Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.

  2013cited by this paper
• DMSO-mediated ligand dissociation: renaissance for biological activity of N-heterocyclic-[Ru(η6-arene)Cl2] drug candidates.

  2013cited by this paper
• Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.

  2013cited by this paper
• COX-2 as a molecular target of colon cancer chemoprevention: Promise and reality

  2012cited by this paper
• Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder.

  2012cited by this paper
• Synthesis, characterization and antiproliferative activity of transition metal complexes with 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid (oxaprozin).

  2012cited by this paper
• Synthesis and characterization of a diruthenium(II,III)–ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives

  2012cited by this paper
• Metal-based antitumour drugs in the post-genomic era: what comes next?

  2011cited by this paper
• Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

  2011cited by this paper
• (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2.

  2011cited by this paper
• Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.

  2011cited by this paper
• Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?

  2010cited by this paper
• [Cyclopentadienyl]metalcarbonyl complexes of acetylsalicylic acid as neo-anticancer agents.

  2010cited by this paper
• Synthesis and antiproliferative properties of ibuprofen-oligo(3-hydroxybutyrate) conjugates.

  2010cited by this paper
• The interactions of metal ions with nonsteroidal anti-inflammatory drugs (oxicams)

  2009cited by this paper
• Rational design of an organometallic glutathione transferase inhibitor.

  2009cited by this paper
• Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

  2008cited by this paper
• Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis.

  2007cited by this paper
• Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.

  2005cited by this paper
• Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.

  2004cited by this paper
• A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

  2004cited by this paper
• Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).

  2004cited by this paper
• Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy

  2002cited by this paper
• Inhibition of cancer cell growth by ruthenium(II) arene complexes.

  2001cited by this paper
• Synthesis, characterization, and antiinflammatory activity of naproxen complexes with rare earth (III).

  1992cited by this paper
• Synthesis and reactions of some triple alkoxo- and thioato-bridged areneruthenium(II) complexes. X-ray structure determination of [Ru2(η-C6H6)2(OMe)3][BPh4]

  1984cited by this paper
• Infrared and Raman Spectra of Inorganic and Coordination Compounds

  1978cited by this paper

• Ru-Based NSAIDs as Potential Anticancer Therapeutics.

  2026cites this paper
• Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro-Substituted Salicyllimidazo[1,5-a]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells.

  2025cites this paper
• Imidazole Derivatives as ON/OFF Fluorescent Chemosensor to Detect Mercury Ion: A Mini Review

  2025cites this paper
• Lighting up imidazole-based fluorescent chemosensor for selective discrimination of Hg2+ ions and its application in sequential detection of histidine, solid-supported extractant.

  2024cites this paper
• Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer

  2024cites this paper
• Ruthenium-based complexes as anti-tumor agents

  2024cites this paper
• Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy.

  2024cites this paper
• Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents

  2024cites this paper
• Bovine serum albumin uptake and polypeptide disaggregation studies of hypoglycemic ruthenium(II) uracil Schiff-base complexes.

  2024cites this paper
• Dinuclear Ru(II) Complexes Containing Tetrapyrido[3,2‐a : 2,3‐c : 3,2‐h : 2′′′,3′′′‐j]Phenazine Ligand for Biomedical Applications

  2024cites this paper
• Positively-charged, chalcone-hydroxypyrone hybrid ruthenium(II)-arene complexes functionalized with ethacrynic acid: Synthesis, characterizaion, and antitumor effect.

  2024cites this paper
• Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design.

  2023cites this paper
• Synthesis, structure and biological activity of silver(I) complexes containing triphenylphosphine and non-steroidal anti-inflammatory drug ligands.

  2023cites this paper
• An Overview of the Potential Medicinal and Pharmaceutical Properties of Ru(II)/(III) Complexes

  2023cites this paper
• Synthesis, Crystal Structure, Hirshfeld Surfaces Analysis, Interaction with DNA and Comparation of Different Bases in Hirshfeld Atom Refinement of New Polymorph of Chlorido(η6-p-cymene)(diclofenac)Ruthenium(II) Organometallic Compound

  2023cites this paper
• Studies on anticancer properties with varying co-ligands in a Ru(II) arene benzimidazole system.

  2023cites this paper
• Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid via cyclooxygenase-2 inhibition.

  2023cites this paper
• Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses.

  2023cites this paper
• Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex: preparation and characterisation. Analytical validation for metal determination by microwave-induced plasma optical emission spectrometry

  2023cites this paper
• Recognition and mechanistic investigation of anion sensing by ruthenium(II) arene complexes and bio-imaging application.

  2022cites this paper
• Acetylsalicylic Acid–Primus Inter Pares in Pharmacology

  2022cites this paper
• Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligands.

  2022cites this paper
• Biomolecular Interactions of Cytotoxic Ruthenium Compounds with Thiosemicarbazone or Benzothiazole Schiff Base Chelates

  2022cites this paper
• Targeting of the intracellular redox balance by metal complexes towards anticancer therapy

  2022cites this paper
• A binuclear Cu(II) complex as an efficient photocatalyst for N-alkylation of aromatic amines.

  2022cites this paper
• Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model

  2022cites this paper
• Cytotoxic Effects of Diclofenac and Ibuprofen Zinc (II)-Nicotinamide Ternary Complexes in Breast Cancer Cell Lines

  2021cites this paper
• The footprint of kynurenine pathway in every cancer: A new target for chemotherapy.

  2021cites this paper
• Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases.

  2021cites this paper
• Utilization of Guanidine-Based Ancillary Ligands in Arene–Ruthenium Complexes for Selective Cytotoxicity

  2021cites this paper
• In vitro evaluation of cytotoxicity and antimetastatic properties of novel arene ruthenium(II)‐tetrazolato compounds on human cancer cell lines

  2021cites this paper
• Metals and Metal Complexes for Medicinal Applications

  2021cites this paper
• An asymmetric Schiff base-functionalized gold nanoparticle-based colorimetric sensor for Hg2+ ion determination: experimental and DFT studies.

  2021cites this paper
• Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies

  2021cites this paper
• Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

  2021cites this paper
• Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer

  2021cites this paper
• Modulation of catalytic and biomolecular binding properties of ruthenium(II)-arene complexes with the variation of coligands for selective toxicity against cancerous cells

  2021cites this paper
• Target based chemotherapeutic advancement of ruthenium complexes

  2021cites this paper
• Co-ordination behaviour of hydrazine and isomers of acetoxy benzoic acids with transition metal ions

  2021cites this paper
• NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.

  2021cites this paper
• Screening the biological properties of transition metal carbamates reveals gold(I) and silver(I) complexes as potent cytotoxic and antimicrobial agents.

  2021cites this paper
• Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.

  2020cites this paper
• Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals

  2020cites this paper
• Mechanistic Insight for Targeting Biomolecules by Ruthenium(II) NSAID Complexes.

  2020cites this paper
• Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization

  2020cites this paper
• Bis-conjugation of Bioactive Molecules to Cisplatin-like Complexes through (2,2'-Bipyridine)-4,4'-Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen.

  2020cites this paper
• Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.

  2020cites this paper
• Mechanistic studies of in vitro anti-proliferative and anti-inflammatory activities of the Zn(ii)-NSAID complexes of 1,10-phenanthroline-5,6-dione in MDA-MB-231 cells.

  2020cites this paper
• OTT_A_243357 5223..5230

  2020cites this paper
• Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity.

  2020cites this paper
• p-Cymene metallo-derivatives: An overview on anticancer activity.

  2020cites this paper
• Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma

  2020cites this paper
• Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner

  2020cites this paper
• Synthesis, characterization, in silico and in vitro biological activity studies of Ru(II) (η6-p-cymene) complexes with novel N-dibenzosuberene substituted aroyl selenourea exhibiting Se type coordination

  2020cites this paper
• Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines

  2020cites this paper
• Antiproliferative Activity of Gold(I) N‐Heterocyclic Carbene and Triphenylphosphine Complexes with Ibuprofen Derivatives as Effective Enzyme Inhibitors

  2020cites this paper
• Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities.

  2020cites this paper
• Top-down mass spectrometry reveals multiple interactions of an acetylsalicylic acid bearing Zeise’s salt derivative with peptides

  2020cites this paper
• Rationally Designed Ruthenium Complexes for Breast Cancer Therapy

  2020cites this paper
• Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.

  2020cites this paper
• Organoruthenium (II) complexes featuring pyrazole-linked Schiff base ligands: Crystal structure, DNA/BSA interactions, cytotoxicity and molecular docking

  2019cites this paper
• Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?

  2019cites this paper
• Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines.

  2019cites this paper
• Insight into the Biological Activity of Organometallic Acetylsalicylic Acid (Aspirin) Derivatives.

  2019cites this paper
• Substituent dependent sensing behavior of Schiff base chemosensors in detecting Zn2+and Al3+ ions: Drug sample analysis and living cell imaging

  2019cites this paper
• A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands

  2019cites this paper
• Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos.

  2019cites this paper
• Urease inhibition studies of six Ni(II), Co(II) and Cu(II) complexes with two sexidentate N2O4-donor bis-Schiff base ligands: An experimental and DFT computational study.

  2019cites this paper
• Synthesis, characterization and biological evaluation of cationic organoruthenium(ii) fluorene complexes: influence of the nature of the counteranion.

  2019cites this paper
• Design, Synthesis, DNA/HSA Binding, and Cytotoxic Activity of Half-Sandwich Ru(II)-Arene Complexes Containing Triarylamine–Thiosemicarbazone Hybrids

  2019cites this paper
• In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories

  2018cites this paper
• Synthesis, theoretical, spectroscopic and electrochemical DNA binding investigations of 1, 3, 4-thiadiazole derivatives of ibuprofen and ciprofloxacin: Cancer cell line studies.

  2018cites this paper
• Synthesis, characterization and behavior in water/DMSO solution of Ru(II) arene complexes with bioactive carboxylates

  2018cites this paper
• Naproxen attenuates osteoarthritis progression through inhibiting the expression of prostaglandinl‐endoperoxide synthase 1

  2018cites this paper